Epidemiology and in vitro activity of ceftazidime-avibactam and comparator agents against multidrug-resistant isolates of Enterobacterales and Pseudomonas aeruginosa collected in Latin America as part of the ATLAS surveillance program in 2015¿2020 Mark G. Wise; James A. Karlowsky; Elkin V. Lemos-Luengas; Rafael R. Valdez; Daniel F. Sahm;

In vitro activity of ceftazidime-avibactam against Enterobacterales and Pseudomonas aeruginosa isolates collected in Latin America as part of the ATLAS global surveillance program, 2017¿2019 James A. Karlowsky; Krystyna M. Kazmierczak; Maria Lavínea Novis de Figueiredo Valente; Elkin Lemos Luengas; Monique Baudrit; Alvaro Quintana; Paurus Irani; Gregory G. Stone; Daniel F. Sahm;

Activity of ceftolozane/tazobactam and comparators against gram-negative bacilli: Results from the Study for Monitoring Antimicrobial Resistance Trends (SMART ¿ Brazil), 2018¿2021 Amanda Azevedo Bittencourt; Vinicius Lima Faustino; Paula de Mendonça Batista; Lays Paulino Leonel; Marina Della Negra de Paula; Thales José Polis;